期刊文献+

RANKL对人子宫内膜癌细胞上皮间质转化的影响 被引量:1

RANKL influenced epithelial-mesenchymal transition of human endometrial cancer cell line
下载PDF
导出
摘要 目的:探讨RANKL对人子宫内膜癌细胞转移和上皮间质转化的影响。方法:体外构建针对细胞核因子κB受体活化因子(RANK)的过表达质粒载体(p IRES2-3FLAG-EGFP-RANK),脂质体法转染人子宫内膜癌HEC-1A细胞株,形成HEC-1ARANK细胞(过表达质粒组),并与HEC-1A^Control细胞(空白质粒组)相对照。给予1μg/ml可溶性细胞因子sRANKL处理后,细胞划痕试验检测细胞迁移能力,CCK-8试验检测细胞的增殖能力,实时荧光定量PCR(qRT-PCR)和Western blot技术分别检测EMT相关指标E-cadherin、N-cadherin及Vimentin mRNA及蛋白的表达变化。结果:经1μg/ml sRANKL刺激后,HEC-1ARANK细胞迁移能力增强(P<0.01),增殖效应没有明显改变(P>0.05),上皮性标记物E-cadherin mRNA及蛋白的表达水平下降,间质性标记物N-cadherin、Vimentin mRNA及蛋白的表达水平显著上调(P<0.01)。结论:RANKL可通过诱导HEC-1A细胞发生上皮间质转化促进子宫内膜癌的转移。 Objective: To explore the effect of RANKL on the metastasis and epithelial-mesenchymal transition of human endometrial cancer cell line. Methods:The over-expression plasmid targeting the receptor activator of nuclear factor κB (RANK),pIRES2-3FLAG-EGFP-RANK,was constructed in vitro,and was transfected into HEC-1A cells with lipofectamine tech-nique. The empty plasmid,pIRES2-3FLAG-EGFP-CON236,was established as blank control group. Both HEC-1AControl cells and HEC-1ARANK cells were treated by sRANKL (1μg / ml),then the migration ability was detected by wound-healing assay. The proliferative ability was detected by CCK-8 assay. The expressions of EMT related markers such as E-cadherin,N-cadherin and Vimentin were detected by qRT-PCR and Western blot. Results:Wound-healing assay showed that the migration potential of HEC-1ARANK cells was significantly increased( P 〈0. 01) after sRANKL (1μg / ml) treatment. CCK-8 assay indicated that the value-added effect was not obvi-ous change(P〉0. 05). After cultured by sRANKL (1μg / ml) in HEC-1ARANK cells,the expres-sion of E-cadherin mRNA and protein was significantly reduced,while the expression of N-cad-herin,Vimentin mRNA and protein got more(P〈0. 01). Conclusion:RANKL can induce EMT in the HEC-1A cells,promoting them to migrate.
出处 《现代妇产科进展》 CSCD 北大核心 2015年第8期590-593,共4页 Progress in Obstetrics and Gynecology
基金 国家自然科学基金面上项目(No:81172477) 上海市科委自然基金(No:11ZR1440800) 上海市卫生系统优秀学科带头人培养计划(No:XBR2013097)
关键词 子宫内膜癌 上皮间质转化 RANKL RANK Endometrial cancer Epithelial-mesenchymal transition RANKL RANK
  • 相关文献

参考文献10

  • 1Siegel R, Ma J,Zou Z,et al. Cancer statistics,2014 [ J]. CA Cancer J Clin,2014,64( 1 ) :9-29.
  • 2李鹏,王志启,赵丽君,李小平,郝娟,王建六.17β-雌二醇对子宫内膜癌细胞上皮间质转化诱导作用的研究[J].现代妇产科进展,2014,23(7):531-533. 被引量:1
  • 3Battula VL, Evans KW, Hollier BG, et al. Epithelial-mes- enchymal transition-derived cells exhibit multilineage dif- ferentiation potential similar to mesenchymal stem cells [ J ]. Stem Cells,2010,28 (8) : 1435-1445.
  • 4刘瑶,王玉东.子宫内膜癌的孕激素拮抗及增敏机制[J].国际妇产科学杂志,2015,42(1):104-107. 被引量:14
  • 5Huang Y, Zhao M, Xu H, et al. RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transi- tion and metastasis [ J ]. Oncotarget, 2014,5 ( 16 ) : 6734- 6745.
  • 6Krebs MG, Metcalf RL, Carter L, et al. Molecular analysis of circulating tumor cells-biology and biomarkers [ J ]. Na- ture Rev Clin Oncol,2014,11 ( 3 ) : 129-144.
  • 7Schieferdecker A, Voigt M, Riecken K, et al. Denosumab mimics the natural decoy receptor osteoprotegerin by in- teracting with its major binding site on RANKL [ J ]. On- cotarget, 2014,5 ( 16 ) : 6647 -6653.
  • 8Wang J, Sun X, Wang Y, et al. MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer [ J ]. Oncol Reports,2015,33 (2) :799-809.
  • 9Boopalan T, Arumugam A, Parada J, et al. Receptor acti- vator for nuclear factor- kB ligaud signaling promotes pro- gesterone-mediated estrogen-induced mammary carcino- genesis [ J ]. Cancer Sci,2015,106 ( 1 ) :25-33.
  • 10Song FN, Duan M, Liu LZ, et al. RANKL promotes mi- gration and invasion of hepatocellular carcinoma cells via NF-kB-mediated epithelial-mesenchymal transition [ J ]. PLoS One. 2014.9 (9) : e108507.

二级参考文献30

  • 1王志启,王建六,郭健,魏丽惠.内分泌辅助治疗子宫内膜癌的临床意义[J].中华医学杂志,2005,85(34):2414-2419. 被引量:21
  • 2Siegel R, Ma J, Zou Z, et al. Cancer statistics ,2014 [ J ]. CA Cancer J C1in,2014,64( 1 ) :9-29.
  • 3Micalizzi I)S, Farabaugh SM, Ford HL. Epithelial-mesen- chymal transition in cancer:parallels between normal de- velopment and tumor progression [ J ]. J Mammary Gland Biol Neoplasia, 2010,15 ( 2 ) : 117-134.
  • 4Bokhman JV. Two pathogenetic types of endometrial carci- noma[ J ]. Gynecol Oncol, 1983,15 ( 1 ) : 10-17.
  • 5Hayashida T, Jinno H, Kitagawa Y, et al. Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis [J]. J Oncol,2011,59(1) :14-27.
  • 6Chai JY, Modak C, Mouazzen W, et al. Epithelial or mes- enchymal: Where to draw the line? [J ]. BioScience Trends, 2010,4 ( 3 ) : 130-142.
  • 7Zhao G, Nie Y, Lv M, et al. ERl3-mediated estradiol en- hances epithelial mesenchymal transition of lung adeno- carcinoma through increasing transcription of midkine [ J ].Mol Endocrinol, 2012,26 ( 8 ) : 1304 - 1315.
  • 8Wang KH, Kao AP, Lin TC, et al. Promotion of epithelial- mesenchymal transition and tumor growth by 17[3-estradiol in an ER (+)/HER2 (+) cell line derived from human breast epithelial stem cells [ J] Biotechnol Appl Bioehem, 2012,59 (3) :262-267.
  • 9Pieotto G, Massheimer V, Boland R. Acute stimulation of intestinal cell calcium influx induced by 17 beta-estradiol via the cAMP messenger system[ J]. Mol Cell Endocrinol, 1996.119(2) :129-134.
  • 10Laurelli G,Di Vagno G,Scaffa C,et al. Conservative treatment of early endometrial cancer:preliminary results of a pilot [.1]. Gynecol Oncol,2011,120( 1 ) :43-46.

共引文献13

同被引文献3

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部